CancerVAX, Inc.
CIK 1905495 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CancerVAX, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 21, 2026 | C/A | 0001905495-26-000013 |
| Aug 20, 2026 | 1-SA | 0001493152-26-039412 |
| Jul 24, 2026 | C/A | 0001905495-26-000011 |
| Jun 15, 2026 | C | 0001905495-26-000009 |
| May 1, 2026 | C-U | 0001905495-26-000007 |
| Mar 31, 2026 | 1-K | 0001493152-26-013976 |
| Feb 20, 2026 | C/A | 0001905495-26-000006 |
| Jan 7, 2026 | C/A | 0001905495-26-000003 |
| Nov 6, 2025 | C/A | 0001905495-25-000004 |
| Sep 26, 2025 | 1-SA | 0001493152-25-015758 |
| Aug 28, 2025 | C/A | 0001665160-25-001398 |
| Jun 2, 2025 | C | 0001665160-25-001164 |
| Apr 25, 2025 | 1-K | 0001641172-25-006205 |
| Oct 18, 2024 | D/A | 0001493152-24-041515 |
| Sep 30, 2024 | 1-SA | 0001493152-24-038664 |
| May 1, 2024 | 1-K | 0001493152-24-017424 |
| Mar 22, 2024 | QUALIF | 9999999994-24-000041 |
| Mar 11, 2024 | 1-A/A | 0001493152-24-009596 |
| Feb 14, 2024 | 1-A/A | 0001493152-24-006532 |
| Dec 8, 2023 | 1-A | 0001493152-23-044240 |
| Oct 26, 2023 | D | 0001493152-23-038418 |
| Oct 11, 2023 | 253G2 | 0001493152-23-036847 |
| Sep 28, 2023 | 1-SA | 0001493152-23-034560 |
| May 30, 2023 | QUALIF | 9999999994-23-000210 |
| Apr 26, 2023 | 1-A/A | 0001493152-23-013677 |